Trial
NCT02721875
Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Myelodysplastic Syndromes
Intervention
Volasertib
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-09